481 related articles for article (PubMed ID: 33915902)
1. Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Zhang T; Hu L; Tang JF; Xu H; Tian K; Wu MN; Huang SY; Du YM; Zhou P; Lu RJ; He S; Xu JM; Si JJ; Li J; Chen DL; Ran JH
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915902
[TBL] [Abstract][Full Text] [Related]
2. p53 inhibits the Urea cycle and represses polyamine biosynthesis in glioma cell lines.
Zhao Y; Chen Y; Wei L; Ran J; Wang K; Zhu S; Liu Q
Metab Brain Dis; 2023 Apr; 38(4):1143-1153. PubMed ID: 36745250
[TBL] [Abstract][Full Text] [Related]
3. Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression.
Meng X; Peng J; Xie X; Yu F; Wang W; Pan Q; Jin H; Huang X; Yu H; Li S; Feng D; Liu Q; Fang L; Lee MH
Oncogene; 2022 Sep; 41(36):4231-4243. PubMed ID: 35906392
[TBL] [Abstract][Full Text] [Related]
4. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts.
Mohamed Suhaimi NA; Phyo WM; Yap HY; Choy SHY; Wei X; Choudhury Y; Tan WJ; Tan LAPY; Foo RSY; Tan SHS; Tiang Z; Wong CF; Koh PK; Tan MH
Mol Cancer Ther; 2017 Sep; 16(9):2035-2044. PubMed ID: 28533437
[TBL] [Abstract][Full Text] [Related]
5. p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis.
Li L; Mao Y; Zhao L; Li L; Wu J; Zhao M; Du W; Yu L; Jiang P
Nature; 2019 Mar; 567(7747):253-256. PubMed ID: 30842655
[TBL] [Abstract][Full Text] [Related]
6. NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms.
Buga GM; Wei LH; Bauer PM; Fukuto JM; Ignarro LJ
Am J Physiol; 1998 Oct; 275(4):R1256-64. PubMed ID: 9756558
[TBL] [Abstract][Full Text] [Related]
7. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
8. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
Mogavero A; Maiorana MV; Zanutto S; Varinelli L; Bozzi F; Belfiore A; Volpi CC; Gloghini A; Pierotti MA; Gariboldi M
Sci Rep; 2017 Nov; 7(1):15992. PubMed ID: 29167573
[TBL] [Abstract][Full Text] [Related]
9. Baicalein Inhibits Proliferation Activity of Human Colorectal Cancer Cells HCT116 Through Downregulation of Ezrin.
Chen Z; Hou R; Gao S; Song D; Feng Y
Cell Physiol Biochem; 2018; 49(5):2035-2046. PubMed ID: 30244250
[TBL] [Abstract][Full Text] [Related]
10. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
11. The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.
Huang YH; Huang SW; Hsu YF; Ou G; Huang WJ; Hsu MJ
Sci Rep; 2015 Oct; 5():15900. PubMed ID: 26510776
[TBL] [Abstract][Full Text] [Related]
12. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
13. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
[TBL] [Abstract][Full Text] [Related]
14. Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells.
Yuan Q; Ray RM; Viar MJ; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G130-8. PubMed ID: 11123206
[TBL] [Abstract][Full Text] [Related]
15. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53.
Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J
Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633
[TBL] [Abstract][Full Text] [Related]
16. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
17. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
18. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.
Buzzai M; Jones RG; Amaravadi RK; Lum JJ; DeBerardinis RJ; Zhao F; Viollet B; Thompson CB
Cancer Res; 2007 Jul; 67(14):6745-52. PubMed ID: 17638885
[TBL] [Abstract][Full Text] [Related]
20. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
